Astec LifeSciences Limited

NSE ASTEC.NS

Astec LifeSciences Limited Revenue for the year ending March 31, 2024: USD 54.93 M

Astec LifeSciences Limited Revenue is USD 54.93 M for the year ending March 31, 2024, a -28.13% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Astec LifeSciences Limited Revenue for the year ending March 31, 2023 was USD 76.43 M, a -14.22% change year over year.
  • Astec LifeSciences Limited Revenue for the year ending March 31, 2022 was USD 89.10 M, a 17.58% change year over year.
  • Astec LifeSciences Limited Revenue for the year ending March 31, 2021 was USD 75.78 M, a 9.27% change year over year.
  • Astec LifeSciences Limited Revenue for the year ending March 31, 2020 was USD 69.35 M, a 11.84% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NSE: ASTEC.NS

Astec LifeSciences Limited

CEO Ms. Tejashree Rohan Pradhan
IPO Date Nov. 25, 2009
Location India
Headquarters Godrej One
Employees 606
Sector Health Care
Industries
Description

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

Similar companies

BALAMINES.NS

Balaji Amines Limited

USD 19.80

0.45%

DHANUKA.NS

Dhanuka Agritech Limited

USD 15.72

3.16%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 153.69

1.58%

SUDARSCHEM.NS

Sudarshan Chemical Industries Limited

USD 12.66

2.02%

BHARATRAS.NS

Bharat Rasayan Limited

USD 110.20

2.04%

StockViz Staff

January 16, 2025

Any question? Send us an email